Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

Use of automated primary screening on liquid-based, thin-layer preparations.

Vassilakos P, Carrel S, Petignat P, Boulvain M, Campana A.

Acta Cytol. 2002 Mar-Apr;46(2):291-5.

PMID:
11917575
2.

Cell differentiation and cell-cycle alterations by tyrosine kinase inhibitors in human melanoma cells.

Hartmann RR, Rimoldi D, Lejeune FJ, Carrel S.

Melanoma Res. 1997 Aug;7 Suppl 2:S27-33.

PMID:
9578414
3.

Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line.

Waanders GA, Rimoldi D, Liénard D, Carrel S, Lejeune F, Dietrich PY, Cerottini JC, Romero P.

Clin Cancer Res. 1997 May;3(5):685-96.

4.
5.

Expression of MAGE genes in primary and metastatic cutaneous melanoma.

Brasseur F, Rimoldi D, Liénard D, Lethé B, Carrel S, Arienti F, Suter L, Vanwijck R, Bourlond A, Humblet Y, et al.

Int J Cancer. 1995 Nov 3;63(3):375-80.

PMID:
7591235
6.

Expression of type A and B tumor necrosis factor (TNF) receptors on melanoma cells can be regulated by dbc-AMP and IFN gamma.

Carrel S, Hartmann F, Salvi S, Albrecht H, Schreyer M, Rimoldi D.

Int J Cancer. 1995 Jul 4;62(1):76-83.

PMID:
7601571
7.

Recognition of HLA-A1 by murine monoclonal antibodies.

Carrel S, Salvi S, Hartmann F, Rimoldi D.

Tissue Antigens. 1994 Feb;43(2):110-5.

PMID:
8016837
8.

Expression of CALLA/CD10 on human melanoma cells.

Carrel S, Zografos L, Schreyer M, Rimoldi D.

Melanoma Res. 1993 Oct;3(5):319-23. Review.

PMID:
8292887
9.

Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67-kilodalton laminin receptor.

Vacca A, Ribatti D, Roncali L, Lospalluti M, Serio G, Carrel S, Dammacco F.

Cancer. 1993 Jul 15;72(2):455-61.

PMID:
7686442
10.

Effects of systemic interferon-alpha (IFN-alpha) on the antigenic phenotype of melanoma metastases. EORTC melanoma group cooperative study No. 18852.

von Stamm U, Bröcker EB, von Depka Prondzinski M, Ruiter DJ, Rümke P, Broding C, Carrel S, Lejeune FJ.

Melanoma Res. 1993 Jun;3(3):173-80.

PMID:
8104570
11.
12.

Expression of IL-2 receptors in human melanoma cells.

Rimoldi D, Salvi S, Hartmann F, Schreyer M, Blum S, Zografos L, Plaisance S, Azzarone B, Carrel S.

Anticancer Res. 1993 May-Jun;13(3):555-64.

PMID:
8317884
13.

Stimulation of human T cells by streptococcal "superantigen" erythrogenic toxins (scarlet fever toxins).

Braun MA, Gerlach D, Hartwig UF, Ozegowski JH, Romagné F, Carrel S, Köhler W, Fleischer B.

J Immunol. 1993 Mar 15;150(6):2457-66.

PMID:
8450222
14.

Immunologic recognition of malignant melanoma by autologous T lymphocytes.

Carrel S, Johnson JP.

Curr Opin Oncol. 1993 Mar;5(2):383-9. Review.

PMID:
8457622
15.

Lectins and anti-T monoclonal antibodies-induced changes of second messengers generating enzymes in human peripheral blood mononuclear cells.

Graber R, Leoni L, Carrel S, Losa GA.

Cell Mol Biol (Noisy-le-grand). 1993 Feb;39(1):45-54.

PMID:
8385519
16.

Purification and characterization of murine lipopolysaccharide-binding protein.

Gallay P, Carrel S, Glauser MP, Barras C, Ulevitch RJ, Tobias PS, Baumgartner JD, Heumann D.

Infect Immun. 1993 Feb;61(2):378-83.

17.

Expression and release of interleukin-1 by human glioblastoma cells in vitro and in vivo.

Gauthier T, Hamou MF, Monod L, Gallay P, Carrel S, de Tribolet N.

Acta Neurochir (Wien). 1993;121(3-4):199-205.

PMID:
8512018
18.

Melanoma-associated antigens.

Carrel S, Rimoldi D.

Eur J Cancer. 1993;29A(13):1903-7. Review. No abstract available.

PMID:
8260252
19.

Inhibition of phosphatidylserine synthesis induced by a CD4 mAb, B66.6 in Jurkat T cells.

Aussel C, Breittmayer JP, Pelassy C, Carrel S.

J Lipid Mediat. 1992 Sep;5(3):219-25.

PMID:
1361369
20.

The differential reactivity of cells of the melanocytic lineage with four monoclonal antibodies against IFN-gamma inducible molecules.

Vacca A, Frassanito A, Rimoldi D, Dammacco F, Carrel S.

Anticancer Res. 1992 Jan-Feb;12(1):1-9.

PMID:
1348919
21.
22.
23.

Cloning of an interferon-gamma regulated human melanoma-associated antigen: identity to the intercellular adhesion molecule ICAM-1.

Hayoz D, Rimoldi D, Kühn L, Mach JP, Carrel S.

Melanoma Res. 1991 Nov-Dec;1(4):251-9.

PMID:
1688067
24.

The EORTC Melanoma Group exchange program: evaluation of a multicenter monoclonal antibody study.

Carrel S, Doré JF, Ruiter DJ, Prade M, Lejeune FJ, Kleeberg UR, Rümke P, Bröcker EB.

Int J Cancer. 1991 Jul 30;48(6):836-47.

PMID:
1860731
25.

Influence of the screen material on the fouling of spin filters.

Esclade LR, Carrel S, Péringer P.

Biotechnol Bioeng. 1991 Jun 20;38(2):159-68.

PMID:
18600746
26.

Direct involvement of CD7 (gp40) in activation of TcR gamma/delta+ T cells.

Carrel S, Salvi S, Rafti F, Favrot M, Rapin C, Sekaly RP.

Eur J Immunol. 1991 May;21(5):1195-200.

PMID:
1709867
27.

gp33-38, an early human T cell activation antigen.

Carrel S.

J Immunol. 1991 Mar 15;146(6):2072. No abstract available.

PMID:
1672342
28.

Positive signal transduction via surface CD4 molecules does not need coexpression of the CD3/TcR complex.

Carrel S, Salvi S, Gallay P, Rapin C, Sekaly RP.

Res Immunol. 1991 Feb;142(2):97-108.

PMID:
1678202
29.

Cell adhesion molecules expression and modulation on human neuroblastoma cells.

Gross N, Carrel S, Beck D, Favre S.

Prog Clin Biol Res. 1991;366:293-9. No abstract available.

PMID:
1712495
30.

An evolutionary conserved mechanism of T cell activation by microbial toxins. Evidence for different affinities of T cell receptor-toxin interaction.

Fleischer B, Gerardy-Schahn R, Metzroth B, Carrel S, Gerlach D, Köhler W.

J Immunol. 1991 Jan 1;146(1):11-7.

PMID:
1670601
31.

Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab')2 fragments of monoclonal antibody Mel-14.

Colapinto EV, Zalutsky MR, Archer GE, Noska MA, Friedman HS, Carrel S, Bigner DD.

Cancer Res. 1990 Mar 15;50(6):1822-7.

32.

gp33-38, an early human T cell activation antigen.

Carrel S, Salvi S, Isler P, Rapin C, Hayoz D, Gallay P, Giuffrè L.

J Immunol. 1990 Mar 15;144(6):2053-62.

PMID:
2138192
33.

Immunoscintigraphy with biosynthetically-labeled 75Se-antibodies--II. Comparison with antibodies labeled by radioiodination.

Ryser JE, Carrel S, Buchegger F, Donath A.

Int J Rad Appl Instrum B. 1990;17(5):495-7.

PMID:
2391245
34.
35.
36.
37.

Characterization of receptors for alpha-melanocyte-stimulating hormone on human melanoma cells.

Siegrist W, Solca F, Stutz S, Giuffrè L, Carrel S, Girard J, Eberle AN.

Cancer Res. 1989 Nov 15;49(22):6352-8.

38.

Human glioma cell lines expressing the common acute lymphoblastic leukemia antigen (cALLa) have neutral endopeptidase activity.

Monod L, Diserens AC, Jongeneel CV, Carrel S, Ronco P, Verroust P, de Tribolet N.

Int J Cancer. 1989 Nov 15;44(5):948-51.

PMID:
2531122
39.

Comparison of the immunosuppressive properties of milk growth factor and transforming growth factors beta 1 and beta 2.

Stoeck M, Ruegg C, Miescher S, Carrel S, Cox D, Von Fliedner V, Alkan S.

J Immunol. 1989 Nov 15;143(10):3258-65.

PMID:
2530275
40.

Monoclonal antibodies to gamma-interferon treated LAN-1 cells detect modulation of ganglioside GD2 exposure on human neuroblastoma cells.

Gross N, Beck D, Portoukalian J, Carrel S, Favre S.

Anticancer Res. 1989 Nov-Dec;9(6):1519-24.

PMID:
2516714
41.

Alteration of melanoma cell phenotype following in vitro culturing and exposure to cytostatic agents.

Engel E, Kleeberg UR, Dietel M, Bröcker EB, Carrel S.

Anticancer Res. 1989 Jul-Aug;9(4):873-7.

PMID:
2683998
42.

Neoplastic meningitis in malignant melanoma: diagnosis with monoclonal antibodies.

Moseley RP, Davies AG, Bourne SP, Popham C, Carrel S, Monro P, Coakham HB.

J Neurol Neurosurg Psychiatry. 1989 Jul;52(7):881-6.

43.
44.

A positive signal is transduced via surface CD4 molecules.

Carrel S, Lamarre D, Isler P, Rapin C, Fleury S, Salvi S, Sekaly RP, Cerottini JC.

Res Immunol. 1989 Jun-Aug;140(5-6):545-61.

PMID:
2476842
45.

V beta-specific stimulation of human T cells by staphylococcal toxins.

Kappler J, Kotzin B, Herron L, Gelfand EW, Bigler RD, Boylston A, Carrel S, Posnett DN, Choi Y, Marrack P.

Science. 1989 May 19;244(4906):811-3.

PMID:
2524876
46.

Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments.

Buchegger F, Pfister C, Fournier K, Prevel F, Schreyer M, Carrel S, Mach JP.

J Clin Invest. 1989 May;83(5):1449-56.

47.

New anti-GD2 monoclonal antibodies produced from gamma-interferon-treated neuroblastoma cells.

Gross N, Beck D, Portoukalian J, Favre S, Carrel S.

Int J Cancer. 1989 Apr 15;43(4):665-71.

PMID:
2467885
48.

In vivo localization of a bispecific antibody which targets human T lymphocytes to lyse human colon cancer cells.

Barr IG, Miescher S, von Fliedner V, Buchegger F, Barras C, Lanzavecchia A, Mach JP, Carrel S.

Int J Cancer. 1989 Mar 15;43(3):501-7.

PMID:
2647641
49.

Common acute lymphoblastic leukemia antigen expressed on leukemia and melanoma cell lines has neutral endopeptidase activity.

Jongeneel CV, Quackenbush EJ, Ronco P, Verroust P, Carrel S, Letarte M.

J Clin Invest. 1989 Feb;83(2):713-7.

50.

Characterization of granzymes A and B isolated from granules of cloned human cytotoxic T lymphocytes.

Krähenbühl O, Rey C, Jenne D, Lanzavecchia A, Groscurth P, Carrel S, Tschopp J.

J Immunol. 1988 Nov 15;141(10):3471-7.

PMID:
3263427

Supplemental Content

Loading ...
Support Center